Jun 1BlueYard is hiring an Associate focusing on Breakthrough EngineeringWe live in a time where the boundary between science fiction and reality is rapidly blurring. Scientists have used high-power lasers to reproduce the sun’s power on Earth, satellites launched by reusable rockets have made high-speed internet ubiquitous and affordable, and new computer architectures have accelerated super-human AI capabilities and…Engineering3 min readEngineering3 min read
Apr 6Sensible BioThe unprecedented speed and success of mRNA vaccines in tackling the COVID-19 pandemic has underscored the demand for mRNA as a next-generation nucleic acid therapy. Hundreds of ongoing clinical trials are currently testing mRNA across more than 20 disease categories. The current production process, called In Vitro Transcription (IVT), has…Biology2 min readBiology2 min read
Feb 6Shell ProtocolIn the wake of several high profile collapses among centralized players in the crypto world, DeFi is naturally receiving renewed attention as an alternative to centralized finance platforms. At BlueYard, we’re long-term believers in the potential of DeFi to deliver a superior coordination mechanism for the world’s financial activities. Despite…Crypto2 min readCrypto2 min read
Feb 2If Web3 is to Work… A BlueYard Conversation in DenverWeb3 hangs in the balance and faces a number of existential problems: from security and usability, regulatory headwinds and damaged public trust, to a lack of real-world use cases. To help facilitate a discussion about what needs to change If Web3 Is To Work (and to gain real & sustainable…Crypto2 min readCrypto2 min read
Feb 1CorintisFor more than 50 years, the technology industry benefited from the tail winds of Moore’s Law. The density of transistors in a silicon microprocessor doubled roughly every 2 years. Up until 10 years ago, that meant that microprocessors got twice as fast every 2 years. Unfortunately, at a certain point…2 min read2 min read
Jan 26CreasallisOver the past five years, antibodies have become the best-selling drugs in the pharmaceutical market (in 2018 eight of the top ten best-selling drugs worldwide were biologics). Targeted monoclonal antibodies (mAbs), therapeutic proteins that bind to specific target sites, have become a cornerstone of treatment guidelines for a wide range…Biology2 min readBiology2 min read
Jan 25BlueYard: Join Our Team as a Bio + Health focused PrincipalWe are at the beginning of a new frontier in biology and medicine unparalleled in human history. Scientific advances like the latest generation of CRISPR, new computational methods, entirely new cell and gene therapies, cell-free synthetic biology and breakthroughs we cannot even imagine today will unlock the applications and treatments…4 min read4 min read
Jan 23VisolisTwo secular trends are disrupting the chemicals space in western economies: A shift from fossil fuels & petrochemicals in an effort to curb greenhouse gas emissions and reduce dependence on Russia/OPEC Moving production of critical commodities onshore and favoring resilience/reliability of supply over lower cost offshore production One of the…Synthetic Biology1 min readSynthetic Biology1 min read
Jan 20ExpressionEditsProteins are a foundational pillar in healthcare and behind every major advancement in biotech and synthetic biology for the last half-century, while biotech’s emergence as a new class of therapeutics was driven by the ability to produce proteins using cells or organisms in a controlled manner. Transgenes, artificial gene constructs…Biology2 min readBiology2 min read
Jan 16BlueYard x Nucleate PartnershipWe are entering a new frontier in biology and medicine unparalleled in human history, with breakthrough advances in gene editing, computational methods, and cell therapies. At the same time, our overall capability of understanding and manipulating biology is improving exponentially. BlueYard’s strategy around biology is based on the premise that…Biology2 min readBiology2 min read
